Want to see FDMT full AI Analyst Report?
4D Molecular Therapeutics (FDMT) Ownership Overview
1.75% Insiders
12.47% Mutual Funds
48.37% Other Institutional Investors
16.55% ETFs
20.86% Public Companies and
Individual Investors
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 77.39% of the company’s stock is owned by Institutional Investors, 1.75% is owned by Insiders, and 20.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 25, 2026 | xxxxxxxxxxxxx | $117720 | |
Dec 19, 2025 | xxxxxxxxxxxxx | $17822 | |
Oct 27, 2025 | xxxxxxxxxxxxx | $32136 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $159640 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $874488 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,049,779 | Institution | 9.14% | 72,262,337 | |
| 2,576,961 | Institution | 4.66% | 36,876,312 | |
| 2,323,901 | Institution | 4.21% | 33,255,023 | |
| 2,147,868 | Institution | 3.89% | 30,735,991 | |
| 1,624,049 | Institution | 2.94% | 23,240,141 | |
| 1,280,128 | Institution | 2.32% | 18,318,632 | |
| 843,751 | Institution | 1.53% | 12,074,077 | |
| 767,486 | Insider | 1.39% | 10,982,725 | |
| 562,084 | Institution | 1.02% | 8,043,422 | |
| 497,649 | Institution | 0.90% | 7,121,357 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,147,868 | Institution | 3.89% | 30,735,991 | |
| 843,751 | Institution | 1.53% | 12,074,077 | |
| 562,084 | Institution | 1.02% | 8,043,422 | |
| 497,649 | Institution | 0.90% | 7,121,357 | |
| 493,296 | Institution | 0.89% | 7,059,066 | |
| 436,172 | Institution | 0.79% | 6,241,621 | |
| 356,881 | Institution | 0.65% | 5,106,967 | |
| 275,427 | Institution | 0.50% | 3,941,360 | |
| 267,501 | Institution | 0.48% | 3,827,939 | |
| 232,021 | Institution | 0.42% | 3,320,221 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,588,533 | Institution | 2.88% | 22,414,201 | |
| 1,205,148 | Institution | 2.18% | 17,462,595 | |
| 1,200,364 | Institution | 2.17% | 17,177,209 | |
| 466,909 | Institution | 0.85% | 6,588,086 | |
| 428,004 | Institution | 0.77% | 6,124,737 | |
| 393,856 | Institution | 0.71% | 5,636,079 | |
| 310,600 | Institution | 0.56% | 4,500,594 | |
| 310,600 | Institution | 0.56% | 4,500,594 | |
| 310,600 | Institution | 0.56% | 4,500,594 | |
| 274,431 | Institution | 0.50% | 3,976,505 |
FAQ
Who Owns 4D Molecular Therapeutics (FDMT)?
According to the latest TipRanks data, approximately 48.37% of the company's stock is held by institutional investors, 1.75% is held by insiders, and 20.86% is held by retail investors.
What percentage of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 48.37% of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors.
What percentage of 4D Molecular Therapeutics (FDMT) stock is held by retail investors?
According to the latest TipRanks data, approximately 20.86% of 4D Molecular Therapeutics (FDMT) stock is held by retail investors.
Who owns the most shares of 4D Molecular Therapeutics (FDMT)?
Peter Kolchinsky owns the most shares of 4D Molecular Therapeutics (FDMT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.